doi:10.1007/s10059-011-1021-7
The interventions encompassed Herba Rhodiolae (0.04 g/kg), venlafaxine (0.035 g/kg), and a synergistic approach combining Herba Rhodiolae with a GSK-3 inhibitor (10 M)
In contrast, DAG may activate protein kinase C (PKC), an enzyme family that modulates diverse cellular functions
The report is segmented by Application (Type 2 diabetes mellitus, Obesity management, and Cardiovascular diseases), Route of Administration (Subcutaneous injection, and Oral administration), Distribution Channel (Hospital pharmacies, Retail pharmacies, and Online pharmacies) and Geography (North America, Europe, Asia, Rest of World (ROW)) Which regions are analyzed in the report
Over six years, they identified approximately 100 cases annually, noting the highest risk within the first year of medication use